Carfilzomib (PR-171) is a proteasome inhibitor that irreversibly binds to the chymotrypsin of the 20S proteasome. Carfilzomib has antitumor activity and may be used to treat multiple myeloma.
Molecular Weight:
719.91
Purity:
99.60%
CAS Number:
[868540-17-4]
Formula:
C40H57N5O7
Target:
Autophagy|||Apoptosis|||Proteasome
T1795
* VAT and and shipping costs not included. Errors and price changes excepted